APPLICATION
ANDA076277
TYPE
ANDA
ORIGINAL APPROVAL
2004-10-04
LATEST ACTION
2021-11-29
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
RIBAVIRINDiscontinued
RIBAVIRIN 200MG · CAPSULE · ORAL
Approval history
2021-11-29Labeling · Supplement 13 · standardAP
2016-02-24Labeling · Supplement 11 · standardAP
2016-02-24Labeling · Supplement 10 · standardAP
2013-09-26Labeling · Supplement 9 · standardAP
2013-09-26Labeling · Supplement 8 · standardAP
2011-04-07Labeling · Supplement 7AP
2011-03-15Labeling · Supplement 6AP
2010-11-26Labeling · Supplement 5AP
2008-06-17Labeling · Supplement 4AP
2008-01-04Labeling · Supplement 3AP
2007-05-09Labeling · Supplement 1AP
2004-10-04OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.